NL
NVCR icon

NVWM LLC’s NovoCure NVCR Stock Holding History

NVWM LLC’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,974
Closed -$289K – 467
2023
Q2 		$289K Buy
6,974
+34
+0.5% +$2.11K 0.09% 184
2023
Q1 		$417K Sell
6,940
-2,963
-30% -$237K 0.14% 177
2022
Q4 		$726K Sell
9,903
-24
-0.2% -$1.81K 0.26% 114
2022
Q3 		$755K Sell
9,927
-6
-0.1% -$468 0.3% 108
2022
Q2 		$690K Hold
9,933
– – 0.27% 126
2022
Q1 		$823K Sell
9,933
-156
-2% -$11.5K 0.26% 138
2021
Q4 		$758K Hold
10,089
– – 0.24% 146
2021
Q3 		$1.17M Buy
10,089
+192
+2% +$29K 0.42% 78
2021
Q2 		$2.19M Sell
9,897
-569
-5% -$111K 0.79% 32
2021
Q1 		$1.38M Sell
10,466
-83
-0.8% -$13.1K 0.55% 48
2020
Q4 		$1.82M Sell
10,549
-839
-7% -$115K 0.76% 40
2020
Q3 		$1.27M Buy
11,388
+138
+1% +$11K 0.6% 51
2020
Q2 		$667K Sell
11,250
-183
-2% -$12K 0.36% 88
2020
Q1 		$770K Buy
11,433
+578
+5% +$45.7K 0.54% 53
2019
Q4 		$915K Sell
10,855
-355
-3% -$28.7K 0.55% 52
2019
Q3 		$838K Sell
11,210
-2,918
-21% -$233K 0.51% 53
2019
Q2 		$893K Buy
14,128
+872
+7% +$44.2K 0.54% 47
2019
Q1 		$639K Sell
13,256
-5,170
-28% -$249K 0.42% 76
2018
Q4 		$617K Buy
18,426
+135
+0.7% +$4.94K 0.46% 67
2018
Q3 		$958K Sell
18,291
-4,438
-20% -$177K 0.61% 52
2018
Q2 		$711K Buy
22,729
+10,889
+92% +$303K 0.49% 64
2018
Q1 		$241K Buy
11,840
+542
+5% +$11.7K 0.18% 136
2017
Q4 		$228K Buy
+11,298
New +$218K 0.17% 131

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

NVWM LLC's NVCR Position: Q3 2023 in Review

NVWM LLC sold out of NovoCure (NVCR) in Q3 2023, closing a stake of 6,974 shares — an estimated $289K sold.

NVWM LLC first reported a position in NVCR in Q4 2017 and held it in 23 quarters. The position peaked at $2.19M in Q2 2021. 226 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.

  • NVWM LLC reported no remaining NovoCure position as of Q3 2023 after selling out during the quarter.
  • NVWM LLC sold 6,974 NovoCure shares in Q3 2023, an estimated $289K.
  • NVWM LLC first reported a position in NovoCure in Q4 2017 and held it in 23 quarters.
  • NVWM LLC's NovoCure position peaked at $2.19M in Q2 2021.
  • 226 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.

Based on NVWM LLC's 13F filing for Q3 2023, filed 30 Oct 2023.